Anthropic introduces a new Life Sciences Verification Program, aiming to shape AI use in scientific research, but details remain limited and development ongoing.
Browsing Category
Technology News & Gadgets
210 posts
Could Trade And Supply-Chain Operations Signal A Shift In Duma Power Balance?
Emerging trade and geopolitical developments could influence Russia’s upcoming Duma elections, signaling a potential shift in power dynamics.
The Future Of Signal Monitoring In Tech Operations With OpenWrt One
OpenWrt One, an open hardware router, is emerging as a key tool for early signal detection in tech operations for small software teams.
How AI And Google Are Transforming Fashion’s Future Landscape
Google’s new AI tools, developed with designers, aim to streamline fashion production processes, showcased at New York Fashion Week, but independent verification is pending.
ex-RUSTEC Wins Map 1
Former RUSTEC team secures victory in Map 1 during recent competition, as market activity indicates strong betting interest.
Why the Worst AI Manager Still Scores 26: Inside a Benchmark That Refuses to Give Out Zeros
A do-nothing AI manager scores 26, not 0 — and one lie caps everything. Inside Firmulate’s honest AI management benchmark and its July 2026 league.
Futurism Investigates Rumors Of Anthropic Insiders Deifying Claude
Unverified reports suggest some Anthropic insiders may be treating the AI model Claude as a deity, sparking debate over AI worship and company culture.
Two Years Away From A Major Multimodal AI Breakthrough? Experts Say Yes
A SenseTime scientist forecasts a significant multimodal AI breakthrough by 2027, signaling rapid progress in integrated AI systems with broad industry implications.
EigenQ Secures $45 Million Financing Ahead Of Planned Nasdaq Listing
EigenQ has secured $45 million in financing ahead of its planned Nasdaq initial public offering, signaling strong investor interest and growth prospects.
Anthropic’s Claude And Novo Nordisk: A New Era In AI-Powered Pharmacology
Novo Nordisk will use Anthropic’s Claude AI models to support early-stage drug research, marking a significant shift in pharmaceutical AI adoption.